ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells

Author:

Liu Mingyang,Zhang Yuqing,Yang JingxuanORCID,Cui Xiaobo,Zhou Zhijun,Zhan Hanxiang,Ding Kai,Tian Xiang,Yang ZhiboORCID,Fung Kar-Ming A.,Edil Barish H.,Postier Russell G.,Bronze Michael S.,Fernandez-Zapico Martin E.,Stemmler Marc P.ORCID,Brabletz Thomas,Li Yi-Ping,Houchen Courtney W.,Li MinORCID

Funder

National Institutes of Health

William and Ella Owens Medical Research Foundation

NIH

National Cancer Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference47 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Crossing the endothelial barrier during metastasis;Reymond;Nat Rev Cancer,2013

3. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors;Samulitis;Cancer Biol Ther,2015

4. Pancreatic cancer;Kamisawa;Lancet,2016

5. Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis;da Rocha Lino;J Gastrointest Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3